Health Robotics has signed an exclusive cooperation agreement with Grifols, contributing to its IV Room of the Future Initiative with its Misterium Clean Room products and IV Therapy and Clinical Nutrition scientific knowledge and experience.
The agreement also includes the appointment of Grifols‘ scientific expert Oriol Prat as an additional member of Health Robotics’ Scientific Advisory Board, where he will join representatives of The Cleveland Clinic Foundation, Ochsner Clinic, Sutter Health, USC University Hospital, and The University of Chicago Medical Center.
Grifols is a Spain-based company engaged in the healthcare sector involved in the research, development, manufacturing and marketing of plasma derivates, IV therapy solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy automation, and medical materials and devices.
Health Robotics executive vice president Gaspar DeViedma said Grifols has designed and constructed more than 1.2 million square feet of clean rooms worldwide and managed more than 150 modular clean room installations at hospitals.
"After witnessing the outstanding combined results of the joint implementation of Misterium and i.v.Station at Vall d’Hebron University Hospital in Barcelona, I was convinced that global hospitals stand to benefit from the synergies between the respective companies’ experience, products, and services within the I.V. Room Technology sector," DeViedma said.
Grifols’ Hospital System Division Marketing vice president Xavier Guix said among the advantages of Misterium modular clean rooms over conventional construction include their flexible, convenient and fast construction, usually within 2 to 4 weeks, with minimal disruption to the pharmacy’s operations, ease of maintenance, GMP compliance, and integrated training tools and workflow analysis.